Erratum: Chlorophyllin abrogates canonical Wnt/β-catenin signaling and angiogenesis to inhibit the development of DMBA-induced hamster cheek pouch carcinomas(Cell Oncology DOI: 10.1007/s13402-012-0099-z);Chlorophyllin abrogates canonical Wnt/β-catenin signaling and angiogenesis to inhibit the development of DMBA-induced hamster cheek pouch carcinomas

Cellular Oncology

Volumn 35, Issue 5, 2012, Pages 385-395

  Siddavaram, Nagini ^a   Ramamurthi, Vidya Priyadarsini ^a   Veeran, Veeravarmal ^b   Mishra, Rajakishore ^c  

^a ANNAMALAI UNIVERSITY   (India)

^b Rajah Muthiah Dental College and Hospital   (India)

^c CENTRAL UNIVERSITY OF JHARKHAND   (India)

Author keywords

Angiogenesis; Chlorophyllin; Hamster buccal pouch; PI3K; Wnt

Indexed keywords

BETA CATENIN; CHLOROPHYLL; DIMETHYLBENZ[A]ANTHRACENE; HISTONE DEACETYLASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; WNT PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANONICAL ANALYSIS; CHEEK POUCH; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; MALE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84870046550     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0121-5     Document Type: Erratum

References (58)

1. R. Dashwood, Chlorophylls as anticarcinogens. Int. J. Oncol. 10, 721-727 (1997) (Pubitemid 27122853)
2. R. Dashwood, T. Negishi, H. Hayatsu, V. Breinholt, J. Hendricks, G. Bailey, Chemopreventive properties of chlorophylls towards aflatoxin B1: a review of the antimutagenicity and anticarcinogenicity data in rainbow trout. Mutat. Res. 399, 245-253 (1998) (Pubitemid 28289325)
3. L.C. Chiu, C.K. Kong, V.E. Ooi, The chlorophyllin-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells is associated with ERK deactivation and cyclin D1 depletion. Int. J. Mol. Med. 16, 735-740 (2005)
4. K. Chimploy, G.D. Diaz, Q. Li, O. Carter, W.M. Dashwood, C.K. Mathews, D.E. Williams, G.S. Bailey, R.H. Dashwood, E2F4 and ribonucleotide reductase mediate S phase arrest in colon cancer cells treated with chlorophyllin. Int. J. Cancer 125, 2086-2094 (2009)
5. X.W. Ding, X.L. Ding, S. Zheng, H.J. Yang, CHL prevent colon neoplasms in mice and its selective inhibition on COX-2. Ai Zheng 23, 1409-1413 (2004)
6. M.T. Simonich, T. McQuistan, C. Jubert, C. Pereira, J.D. Hendricks, M. Schimerlik, B. Zhu, R.H. Dashwood, D.E. Williams, G.S. Bailey, Low-dose dietary chlorophyll inhibits multi-organ carcinogenesis in the rainbow trout. Food Chem. Toxicol. 46, 1014-1024 (2008)
7. A.P. Reddy, U. Harttig, M.C. Barth, W.M. Baird, M. Schimerlik, J.D. Hendricks, G.S. Bailey, Inhibition of dibenzo[a, l]pyreneinduced multi-organ carcinogenesis by dietary chlorophyllin in rainbow trout. Carcinogenesis 20, 1919-1926 (1999) (Pubitemid 29476117)
8. P. Thiyagarajan, R. Senthil Murugan, K. Kavitha, P. Anitha, D. Prathiba, S. Nagini, Dietary chlorophyllin inhibits the canonical NF-?B signaling pathway and induces intrinsic apoptosis in a hamster model of oral oncogenesis. Food Chem. Toxicol. 50, 867-876 (2012)
9. D.T. Shaughnessy, L.M. Gangarosa, B. Schliebe, D.M. Umbach, Z. Xu, B. MacIntosh, M.G. Knize, P.P. Matthews, A.E. Swank, R.S. Sandler, D.M. DeMarini, J.A. Taylor, Inhibition of fried meatinduced colorectal DNA damage and altered systemic genotoxicity in humans by crucifera, chlorophyllin, and yogurt. PLoS One 6, e18707 (2011)
10. P.A. Egner, J.B. Wang, Y.R. Zhu, B.C. Zhang, Y. Wu, Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Natl. Acad. Sci. USA 98, 14601-14606 (2001) (Pubitemid 33121438)
11. J.P. Kamat, K.K. Boloor, T.P. Devasagayam, Chlorophyllin as an effective antioxidant against membrane damage in vitro and ex vivo. Biochim. Biophys. Acta 1487, 113-127 (2000)
12. S. Arimoto, S. Fukuoka, C. Itome, H. Nakano, H. Rai, H. Hayatsu, Binding of polycyclic planar mutagens to chlorophyllin resulting in inhibition of the mutagenic activity. Mutat. Res. 287, 293-305 (1993) (Pubitemid 23174197)
13. M. Hirose, A. Nishikawa, M. Shibutani, T. Imai, T. Shirai, Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats. Environ. Mol. Mutagen. 39, 271-278 (2002) (Pubitemid 34260502)
14. V. Breinholt, M. Schimerlik, R. Dashwood, G. Bailey, Mechanisms of chlorophyllin anticarcinogenesis against aflatoxin B1: complex formation with the carcinogen. Chem. Res. Toxicol. 8, 506-514 (1995)
15. K. John, R.L. Divi, C. Keshava, C.C. Orozco, M.E. Schockley, D.L. Richardson, M.C. Poirier, J. Nath, A. Weston, CYP1A1 and CYP1B1 gene expression and DNA adduct formation in normal human mammary epithelial cells exposed to benzo[a]pyrene in the absence or presence of chlorophyllin. Cancer Lett. 292, 254-260 (2010)
16. Y. Zhang, L. Guan, X. Wang, T. Wen, J. Xing, J. Zhao, Protection of chlorophyllin against oxidative damage by inducing HO-1 and NQO1 expression mediated by PI3K/Akt and Nrf2. Free. Radic. Res. 42, 362-371 (2008)
17. N. Tachino, D. Guo, W.M. Dashwood, S. Yamane, R. Larsen, R. Dashwood, Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo[a]pyrene: studies of enzyme inhibition, molecular complex formation and degradation of the ultimate carcinogen. Mutat. Res. 308, 191-203 (1994) (Pubitemid 24238949)
18. G.D. Diaz, Q. Li, R.H. Dashwood, Caspase-8 and apoptosisinducing factor mediate a cytochrome c-independent pathway of apoptosis in human colon cancer cells induced by the dietary phytochemical chlorophyllin. Cancer Res. 63, 1254-1261 (2003) (Pubitemid 36348703)
19. M.S. Khan, D. Halagowder, S.N. Devaraj, Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-?B signaling pathway and upregulates apoptotic gene expressionin the early hepatocarcinogenesis rat model. Chem. Biol. Interact. 193, 12-21 (2011)
20. S. Huang, C.A. Pettaway, H. Uehara, C.D. Bucana, I.J. Fidler, Blockade of NfkappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20, 4188-4197 (2001) (Pubitemid 32762193)
21. H.L. Pahl, Activators and target genes of Rel/NF-?B transcription factors. Oncogene 18, 6853-6866 (1999)
22. R.S. Tarapore, I.A. Siddiqui, H. Mukhtar, Modulation of Wnt/ß-catenin signalling pathway by bioactive food components. Carcinogenesis 33, 483-491 (2012)
23. R. Jr, Roskoski, Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit. Rev. Oncol. Hematol. 62, 179-213 (2007) (Pubitemid 46679285)
24. A. Surazynski, P. Steven, S.P. Donald, K. Sandra, S.K. Cooper, M.A. Whiteside, K. Salnikow, Y. Liu, J.M. Phang, Extracellular matrix and HIF-1 signaling: the role of prolidase. Int. J. Cancer 22, 1435-1440 (2008) (Pubitemid 351287248)
25. H.P. Gerber, A. McMurtrey, J. Kowalski, M. Yan, B.A. Keyt, V. Dixit, N. Ferrara, Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway. Requirement for Flk-1/ KDR activation. J. Biol. Chem. 273, 30336-30343 (1998) (Pubitemid 28545503)
26. I.H. Koumakpayi, C. Le Page, A.M. Mes-Masson, F. Saad, Hierarchical clustering of immunohistochemical analysis of the activated erbB/PI3K/Akt/NF- kappaB signalling pathway and prognostic significance in prostate cancer. Br. J. Cancer 102, 1163-1173 (2010)
27. O. Witt, H.E. Deubzer, T. Milde, I. Oehme, HDAC family: what are the cancer relevant targets? Cancer Lett. 77, 8-21 (2009)
28. G. Shklar, Development of experimental oral carcinogenesis and its impact on current oral cancer research. J. Dent. Res. 78, 1768-1772 (1999) (Pubitemid 32501235)
29. E. Madrigal-Bujaidar, N. Velazquez-Guadarrama, S. Diaz-Barriga, Inhibitory effect of chlorophyllin on the frequency of sister chromatid exchanges produced by benzo[a]pyrene in vivo. Mutat. Res. 388, 79-83 (1997) (Pubitemid 27226925)
30. S. Nagini, P. Vidjaya Letchoumy, A. Thangavelu, R. Cr, Of humans and hamsters: a comparative evaluation of carcinogen activation, DNA damage, cell proliferation, apoptosis, invasion, and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral. Oncol. 45, e31-e37 (2009)
31. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976)
32. S. Legrand-Poels, S. Schoonbrodt, J. Piette, Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line. Biochem. J. 349, 765-773 (2000) (Pubitemid 30609407)
33. Y. Fu, S. Zheng, N. An, T. Athanasopoulos, L. Popplewell, A. Liang, K. Li, C. Hu, Y. Zhu, ß-catenin as a potential key target for tumor suppression. Int. J. Cancer 129, 1541-1551 (2011)
34. A. Bafico, G. Liu, L. Goldin, V. Harris, S.A. Aaronson, An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 6, 497-506 (2004) (Pubitemid 39469985)
35. R. Najdi, R.F. Holcombe, M.L. Waterman, Wnt signaling and colon carcinogenesis: beyond APC. J. Carcinog. 10, 5 (2011)
36. C. Gaston-Massuet, C.L. Andoniadou, M. Signore, S.A. Jayakody, N. Charolidi, R. Kyeyune, B. Vernay, T.S. Jacques, M.M. Taketo, P. Le Tissier, M.T. Dattani, J.P. Martinez-Barbera, Increased wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Nutr. Cancer 63, 558-564 (2011)
37. L. Queimado, D. Obeso, M.D. Hatfield, Y. Yang, D.M. Thompson, A.M. Reis, Dysregulation of Wnt pathway components in human salivary gland tumors. Arch. Otolaryngol. Head Neck Surg. 134, 94-101 (2008) (Pubitemid 351159282)
38. I. Gehrke, R.K. Gandhirajan, K.A. Kreuzer, Targeting the WNT/bcatenin/ TCF/LEF1 axis in solid and haematological cancers: multiplicity of therapeutic options. Eur. J. Cancer 45, 2759-2767 (2009)
39. R. Vidya Priyadarsini, R. Senthil Murugan, S. Nagini, Aberrant activation of Wnt/ß-catenin signaling pathway contributes to the sequential progression of DMBA induced HBP carcinomas. Oral Oncol. 48, 33-39 (2012)
40. J.K. Sethi, A. Vidal-Puig, Wnt signalling and the control of cellular metabolism. Biochem. J. 427, 1-17 (2010)
41. B.W. Doble, J.R. Woodgett, GSK-3: tricks of the trade for a multitasking kinase. J. Cell. Sci. 116, 1175-1186 (2003) (Pubitemid 36410657)
42. R. Mishra, Gliycogen synthase kinase 3 beta: can it be a target for oral cancer. Mol. Cancer 9, 144 (2010)
43. J. Luo, Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett. 273, 194-200 (2009)
44. O. Carter, G.S. Bailey, R.H. Dashwood, The dietary phytochemical chlorophyllin alters E-cadherin and beta-catenin expression in human colon cancer cells. J. Nutr. 134, 3441-344 (2004)
45. S. Song, N. Mazurek, C. Liu, Y. Sun, Q.Q. Ding, K. Liu, M.C. Hung, R.S. Bresalier, Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity. Cancer Res. 69, 1343-1349 (2009)
46. A. Iamaroon, S. Krisanaprakornkit, Overexpression and activation of Akt2 protein in oral squamous cell carcinoma. Oral Oncol. 45, e175-e179 (2009)
47. J.A. Morrison, M.L. Gulley, R. Pathmanathan, N. Raab-Traub, Differential signalling pathways are activated in the Epstein-Barr virus-Associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res. 64, 5251-5260 (2004) (Pubitemid 39006545)
48. K.H. Chun, H.Y. Lee, K. Hassan, F. Khuri, W.K. Hong, R. Lotan, Implication of protein kinase B/Akt and Bcl-2/Bcl-XL suppression by the farnesyl transferase inhibitor SCH66336 in apoptosis induction in squamous carcinoma cells. Cancer Res. 63, 4796-4800 (2003) (Pubitemid 37022608)
49. P. Amornphimoltham, V. Sriuranpong, V. Patel, F. Benavides, C.J. Conti, J. Sauk, E.A. Sausville, A.A. Molinolo, J.S. Gutkind, Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin. Cancer Res. 10, 4029-4037 (2004) (Pubitemid 38812478)
50. Y. Li, Z.Wang, D. Kong, R. Li, S.H. Sarkar, F.H. Sarkar, Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. J. Biol. Chem. 283, 27707-27716 (2008)
51. P. Roy, N. Kalra, S. Prasad, J. George, Y. Shukla, Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm. Res. 26, 211-217 (2009)
52. C. Hope, K. Planutis, M. Planutiene, M.P. Moyer, K.S. Johal, J. Woo, C. Santoso, J.A. Hanson, R.F. Holcombe, Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol. Nutr. Food Res. 52, S52-S61 (2008)
53. M. Potente, H. Gerhardt, P. Carmeliet, Basic and therapeutic aspects of angiogenesis. Cell 146, 873-887 (2011)
54. X. Lu, Y. Kang, Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin. Cancer Res. 16, 5928-5935 (2011)
55. L. Ellis, H. Hammers, R. Pili, Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett. 280, 145-153 (2009)
56. D.Z. Qian, S.K. Kachhap, S.J. Collis, H.M. Verheul, M.A. Carducci, P. Atadja, R. Pili, Class II histone deacetylases are associated with VHL independent regulation of hypoxia-inducible factor 1a. Cancer Res. 66, 668814-668821 (2006)
57. P. Anitha, R. Vidya Priyadarsini, K. Kavitha, P. Thiyagarajan, S. Nagini, Ellagic acid coordinately attenuates Wnt/ß-catenin and NF-?B signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis. Eur. J. Nutr. (2012).
58. T.A. Bhat, R.P. Singh, Tumor angiogenesis -A potential target in cancer chemoprevention. Food Chem. Toxicol. 6, 1334-1345 (2008) (Pubitemid 351258200)